Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Akouos Stock Is on Fire Today


Shares of small-cap gene therapy company Akouos (NASDAQ: AKUS) popped by as much as 87% in premarket trading Tuesday morning. The biotech's stock is racing higher this morning in response to an all-cash buyout agreement with pharma heavyweight Eli Lilly (NYSE: LLY)

Lilly and Akouos reportedly agreed to a $487 million buyout ($12.5 per share), plus a contingent value right (CVR) option worth another $123 million (an additional $3 per share). The upfront portion of this deal represents a 78% premium over Akouos' closing price Monday afternoon.  

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments